In contrast to HL patients, PD-1 blockade has not shown remarkable clinical responses in patients with NHL such as diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL). This evidence concerns the gene PDCD1 and Hodgkins lymphoma.